Avidity Biosciences, Inc. (RNAM)
Market Closed
27 Feb, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
72. 86
+0.04
+0.0549%
$
11.26B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 72.82
Previous Close Investors:
Want to track RNAM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avidity Biosciences, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 187 | $5,716.88 | $13,624.82 | $7,907.94 | 138.33% |
 Kasey Fegan Corsicana & Co. | 8,000 | $348,560 | $582,880 | $234,320 | 67.23% |
 Timothy Tenneriello Oliver Lagore Vanvalin Investment Group | 663 | $15,303.11 | $48,306.18 | $33,003.07 | 215.66% |
 Michael Byun SageView Advisory Group LLC | 45 | $3,247 | $3,210.3 | -$36.7 | -1.13% |
